A citation-based method for searching scientific literature

Nana Weber-Lassalle, Julika Borde, Konstantin Weber-Lassalle, Judit Horváth, Dieter Niederacher, Norbert Arnold, Silke Kaulfuß, Corinna Ernst, Victoria G Paul, Ellen Honisch, Kristina Klaschik, Alexander E Volk, Christian Kubisch, Steffen Rapp, Nadine Lichey, Janine Altmüller, Louisa Lepkes, Esther Pohl-Rescigno, Holger Thiele, Peter Nürnberg, Mirjam Larsen, Lisa Richters, Kerstin Rhiem, Barbara Wappenschmidt, Christoph Engel, Alfons Meindl, Rita K Schmutzler, Eric Hahnen, Jan Hauke. Breast Cancer Res 2019
Times Cited: 25







List of co-cited articles
421 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families.
L S Friedman, E A Ostermeyer, C I Szabo, P Dowd, E D Lynch, S E Rowell, M C King. Nat Genet 1994
535
12

Mechanisms of BRCA1-BARD1 nucleosome recognition and ubiquitylation.
Qi Hu, Maria Victoria Botuyan, Debiao Zhao, Gaofeng Cui, Elie Mer, Georges Mer. Nature 2021
24
12

Human BRCA1-BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection.
Ruth M Densham, Alexander J Garvin, Helen R Stone, Joanna Strachan, Robert A Baldock, Manuel Daza-Martin, Alice Fletcher, Sarah Blair-Reid, James Beesley, Balraj Johal,[...]. Nat Struct Mol Biol 2016
162
12

E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks.
Latarsha J Reid, Reena Shakya, Ami P Modi, Maria Lokshin, Jiin-Tsuey Cheng, Maria Jasin, Richard Baer, Thomas Ludwig. Proc Natl Acad Sci U S A 2008
103
12


The role of BRCA1 in transcriptional regulation and cell cycle control.
P B Mullan, J E Quinn, D P Harkin. Oncogene 2006
211
12

Structural insight into BRCA1-BARD1 complex recruitment to damaged chromatin.
Linchang Dai, Yaxin Dai, Jinhua Han, Yan Huang, Longge Wang, Jun Huang, Zheng Zhou. Mol Cell 2021
22
13

The genetic landscape of high-risk neuroblastoma.
Trevor J Pugh, Olena Morozova, Edward F Attiyeh, Shahab Asgharzadeh, Jun S Wei, Daniel Auclair, Scott L Carter, Kristian Cibulskis, Megan Hanna, Adam Kiezun,[...]. Nat Genet 2013
719
12

The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers.
Andrea K Watters, Emily S Seltzer, Danny MacKenzie, Melody Young, Jonathan Muratori, Rama Hussein, Andrej M Sodoma, Julie To, Manrose Singh, Dong Zhang. Genes (Basel) 2020
8
37

Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.
R Scully, J Chen, R L Ochs, K Keegan, M Hoekstra, J Feunteun, D M Livingston. Cell 1997
770
12

Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer.
Barbara Wappenschmidt, Jan Hauke, Ulrike Faust, Dieter Niederacher, Lisa Wiesmüller, Gunnar Schmidt, Evi Groß, Andrea Gehrig, Christian Sutter, Juliane Ramser,[...]. Geburtshilfe Frauenheilkd 2020
9
33

Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.
Jan Hauke, Judit Horvath, Eva Groß, Andrea Gehrig, Ellen Honisch, Karl Hackmann, Gunnar Schmidt, Norbert Arnold, Ulrike Faust, Christian Sutter,[...]. Cancer Med 2018
75
12

High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.
Ulrich Bick, Christoph Engel, Barbara Krug, Walter Heindel, Eva M Fallenberg, Kerstin Rhiem, David Maintz, Michael Golatta, Dorothee Speiser, Dorothea Rjosk-Dendorfer,[...]. Breast Cancer Res Treat 2019
48
12

Pathogenic Germline Variants in 10,389 Adult Cancers.
Kuan-Lin Huang, R Jay Mashl, Yige Wu, Deborah I Ritter, Jiayin Wang, Clara Oh, Marta Paczkowska, Sheila Reynolds, Matthew A Wyczalkowski, Ninad Oak,[...]. Cell 2018
372
8

Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.
Rachel S van der Post, Ingrid P Vogelaar, Fátima Carneiro, Parry Guilford, David Huntsman, Nicoline Hoogerbrugge, Carlos Caldas, Karen E Chelcun Schreiber, Richard H Hardwick, Margreet G E M Ausems,[...]. J Med Genet 2015
327
8


Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study.
Elaine F Harkness, Emma Barrow, Katy Newton, Kate Green, Tara Clancy, Fiona Lalloo, James Hill, D Gareth Evans. J Med Genet 2015
49
8

The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations.
Sharon Cantor, Ronny Drapkin, Fan Zhang, Yafang Lin, Juliana Han, Sushmita Pamidi, David M Livingston. Proc Natl Acad Sci U S A 2004
183
8

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Maren Weischer, Stig Egil Bojesen, Christina Ellervik, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard. J Clin Oncol 2008
196
8

Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers.
Lisa Golmard, Laurent Castéra, Sophie Krieger, Virginie Moncoutier, Khadija Abidallah, Henrique Tenreiro, Anthony Laugé, Julien Tarabeux, Gael A Millot, André Nicolas,[...]. Eur J Hum Genet 2017
21
9

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.
D W Bell, J M Varley, T E Szydlo, D H Kang, D C Wahrer, K E Shannon, M Lubratovich, S J Verselis, K J Isselbacher, J F Fraumeni,[...]. Science 1999
672
8

Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination.
Rémi Buisson, Anne-Marie Dion-Côté, Yan Coulombe, Hélène Launay, Hong Cai, Alicja Z Stasiak, Andrzej Stasiak, Bing Xia, Jean-Yves Masson. Nat Struct Mol Biol 2010
215
8

Germline RAD51C mutations confer susceptibility to ovarian cancer.
Chey Loveday, Clare Turnbull, Elise Ruark, Rosa Maria Munoz Xicola, Emma Ramsay, Deborah Hughes, Margaret Warren-Perry, Katie Snape, Diana Eccles, D Gareth Evans,[...]. Nat Genet 2012
174
8

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
8

Rare variants in the ATM gene and risk of breast cancer.
David E Goldgar, Sue Healey, James G Dowty, Leonard Da Silva, Xiaoqing Chen, Amanda B Spurdle, Mary Beth Terry, Mary J Daly, Saundra M Buys, Melissa C Southey,[...]. Breast Cancer Res 2011
140
8

Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.
Ella R Thompson, Maria A Doyle, Georgina L Ryland, Simone M Rowley, David Y H Choong, Richard W Tothill, Heather Thorne, Daniel R Barnes, Jason Li, Jason Ellul,[...]. PLoS Genet 2012
139
8

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.
Silvia Casadei, Barbara M Norquist, Tom Walsh, Sunday Stray, Jessica B Mandell, Ming K Lee, John A Stamatoyannopoulos, Mary-Claire King. Cancer Res 2011
174
8

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Sapna Syngal, Randall E Brand, James M Church, Francis M Giardiello, Heather L Hampel, Randall W Burt. Am J Gastroenterol 2015
800
8

Homologous recombination DNA repair defects in PALB2-associated breast cancers.
Anqi Li, Felipe C Geyer, Pedro Blecua, Ju Youn Lee, Pier Selenica, David N Brown, Fresia Pareja, Simon S K Lee, Rahul Kumar, Barbara Rivera,[...]. NPJ Breast Cancer 2019
26
8

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response.
J S Lee, K M Collins, A L Brown, C H Lee, J H Chung. Nature 2000
440
8

Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.
Daniel J Park, Kayoko Tao, Florence Le Calvez-Kelm, Tu Nguyen-Dumont, Nivonirina Robinot, Fleur Hammet, Fabrice Odefrey, Helen Tsimiklis, Zhi L Teo, Louise B Thingholm,[...]. Cancer Discov 2014
34
8

Cancer risk of heterozygotes with the NBN founder mutation.
Eva Seemanová, Petr Jarolim, Pavel Seeman, Raymonda Varon, Martin Digweed, Michael Swift, Karl Sperling. J Natl Cancer Inst 2007
57
8

Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes.
Darren R Hodgson, Brian A Dougherty, Zhongwu Lai, Anitra Fielding, Lynda Grinsted, Stuart Spencer, Mark J O'Connor, Tony W Ho, Jane D Robertson, Jerry S Lanchbury,[...]. Br J Cancer 2018
117
8

CHEK2 contribution to hereditary breast cancer in non-BRCA families.
Alexis Desrichard, Yannick Bidet, Nancy Uhrhammer, Yves-Jean Bignon. Breast Cancer Res 2011
51
8

Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics Group.
Amy Taylor, Angela F Brady, Ian M Frayling, Helen Hanson, Marc Tischkowitz, Clare Turnbull, Lucy Side. J Med Genet 2018
52
8

Breast cancer risk among male BRCA1 and BRCA2 mutation carriers.
Yu Chuan Tai, Susan Domchek, Giovanni Parmigiani, Sining Chen. J Natl Cancer Inst 2007
207
8

Ovarian cancer linked to Lynch syndrome typically presents as early-onset, non-serous epithelial tumors.
Zohreh Ketabi, Katarina Bartuma, Inge Bernstein, Susanne Malander, Henrik Grönberg, Erik Björck, Susanne Holck, Mef Nilbert. Gynecol Oncol 2011
75
8

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.
Dung T Le, Jennifer N Uram, Hao Wang, Bjarne R Bartlett, Holly Kemberling, Aleksandra D Eyring, Andrew D Skora, Brandon S Luber, Nilofer S Azad, Dan Laheru,[...]. N Engl J Med 2015
8

Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles.
Sheila Seal, Deborah Thompson, Anthony Renwick, Anna Elliott, Patrick Kelly, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Munaza Ahmed, Katarina Spanova,[...]. Nat Genet 2006
508
8

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman,[...]. Lancet 2010
8

Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.
Rohit Prakash, Yu Zhang, Weiran Feng, Maria Jasin. Cold Spring Harb Perspect Biol 2015
449
8

Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.
Piera Rizzolo, Veronica Zelli, Valentina Silvestri, Virginia Valentini, Ines Zanna, Simonetta Bianchi, Giovanna Masala, Alessandro Mauro Spinelli, Maria Grazia Tibiletti, Antonio Russo,[...]. Int J Cancer 2019
24
8

ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles.
Anthony Renwick, Deborah Thompson, Sheila Seal, Patrick Kelly, Tasnim Chagtai, Munaza Ahmed, Bernard North, Hiran Jayatilake, Rita Barfoot, Katarina Spanova,[...]. Nat Genet 2006
493
8

Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder.
Regina Waltes, Reinhard Kalb, Magtouf Gatei, Amanda W Kijas, Markus Stumm, Alexandra Sobeck, Britta Wieland, Raymonda Varon, Yaniv Lerenthal, Martin F Lavin,[...]. Am J Hum Genet 2009
165
8

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
348
8

Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer.
Francis M Giardiello, John I Allen, Jennifer E Axilbund, C Richard Boland, Carol A Burke, Randall W Burt, James M Church, Jason A Dominitz, David A Johnson, Tonya Kaltenbach,[...]. Am J Gastroenterol 2014
285
8


American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015
348
8

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
8

BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.
S B Cantor, D W Bell, S Ganesan, E M Kass, R Drapkin, S Grossman, D C Wahrer, D C Sgroi, W S Lane, D A Haber,[...]. Cell 2001
504
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.